Oscotec

Korean, clinical-stage, biopharma developing small molecule therapeutics for arthritis and cancer indications

placeCheonan, Hoseo, South Korea calendar_todayFounded 1998 groups47 employees language oscotec.com

Innovation

36 patent families (15 granted) — focus: Human necessities, Chemistry & metallurgy, Construction; filing pace slowing. Cited 713 times.

YearFilings
20147
20155
20167
20175
20184
20194
20209
20215
20225
20233
20243
20254

Social engagement

Social engagement: 499 social following, 10 posts in the last 12 months — top quartile of its industry.

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital125%
Private equity375%

Recent activity

18 Jun 2026
Event
BIO USA 2026
11 Jun 2026
Event
KSBMB INTERNATIONAL CONFERENCE 2026
2 Jun 2026
Product launch
(SKI-O-703)
Coming soon